Cost-utility analysis of a structured medication review compared to usual care in Parkinson's disease.
Oonk NGM, Dorresteijn LDA, van den Berg AD, van der Palen J, Movig KLL, Nijmeijer HW, van Kesteren ME, Koffijberg H.
Oonk NGM, et al. Among authors: van den berg ad, van kesteren me, van der palen j.
Eur J Clin Pharmacol. 2023 Feb;79(2):289-297. doi: 10.1007/s00228-022-03438-4. Epub 2022 Dec 23.
Eur J Clin Pharmacol. 2023.
PMID: 36562830
Clinical Trial.